Skip to content

Ayurvedic Treatment for Ulcerative colitis

A CLINICAL STUDY OF UDUMBARA KWATH BASTI IN THE MANAGEMENT OF RAKTATISARA (ULCERATIVE COLITIS) - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065982
Enrollment
15
Registered
2024-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K519- Ulcerative colitis, unspecified

Interventions

None listed

Sponsors

JS Ayurveda Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients fulfillling the diagnostic criteria. 2. Patients will be selected between 18 to 60 years of age irrelevant to gender. 3. Patients with diagnosed Ulcerative colitis. 4. Patients indicated for basti.

Exclusion criteria

Exclusion criteria: 1. Patients with complications of Ulcerative colitis anal fistula colonic perforation cancer. 2. Severe anaemia. 3. Patients in remission period. 4. Severe systemic illness like uncontrolled Diabetes mellitus, AIDS, Hepatitis Cancer, Tuberculosis, uncontrolled Hypertension. 5. Patients contraindicated for basti.

Design outcomes

Primary

MeasureTime frame
Blood in stool 0-3 Frequency of stool 0-3 Abdominal pain 0-3 Weakness 0-3 Red blood cells in stool Pus cells in stool Timepoint: Baseline and after 2 weeks

Secondary

MeasureTime frame
Patients will be assessed based on following criteria 1) Blood in stool 2) Frequency of stool 3) Abdominal pain 4) Weakness 5) Blood cells in stool 6) Pus cells in stoolTimepoint: Baseline & after 4 weeks

Countries

India

Contacts

Public ContactDr Rutu Divyeshkumar Shah

J.S. Ayurveda Mahavidyalaya and P.D.Patel Ayurveda Hospital

drkalapi@rediffmail.com9428661664

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026